Insider · CIK 0001493324
Marvin L White
Files at EBS (Emergent BioSolutions Inc.), APVO (Aptevo Therapeutics Inc.). First filing Nov 13, 2024, latest Nov 13, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EBS: Emergent BioSolutions Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Emergent BioSolutions Inc. | $171k 14,287 shares | -21% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 12, 2024 | EBS Emergent BioSolutions Inc. | 14,287 0.03% of outstanding | $168k | Nov 11, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | AGrant or award Restricted Stock Unitderivative | +30,000 | $0.00 | $0 | 30,000 | Aug 8, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +10 | - | - | 12 | Jul 21, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -10 | $0.00 | $0 | 20 | Jul 21, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +34,403 | $0.00 | $0 | 88,495 | May 2, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,824 | $0.00 | $0 | 41,572 | May 2, 2025 |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +8 | - | - | 49 | Mar 4, 2025 |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +6 | - | - | 55 | Mar 4, 2025 |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -8 | $0.00 | $0 | 8 | Mar 4, 2025 |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -6 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Nov 11, 2024 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock | -14,287 | $11.97 | $171k | 54,092 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.